坚持denosumab治疗和与药物戒断相关的骨折风险:一个回顾性研究
Hande Özdemir1, Nur Kakilli, Filiz Tuna
1Hande Özdemir, Trakya University, Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Edirne 22030, Turkey, handeozdemir@trakya.edu.tr.
Croatian medical journal
|November 7, 2025
概括
停止使用登苏马布后的脆弱性骨折可能是骨质疏松症进展的结果,而不仅仅是反弹效应. 预防非计划性停用登苏马布对于治疗骨质疏松症至关重要.
科学领域:
- 骨质疏松症管理管理
- 药物监督 药物监督 药物监督
- 骨健康 骨健康 骨健康
背景情况:
- 德诺苏马布是骨质疏松症的关键治疗方法.
- 停止服用登苏马布可能会导致反弹效应,增加骨折风险.
- 了解断裂患病率在停药后是非常重要的.
研究的目的:
- 为了确定在停止服用德诺苏马布后脆弱性骨折的发生率.
- 为了确定影响坚持denosumab治疗的因素.
主要方法:
- 在210名骨质疏松症患者的回顾性评估中,他们接受了denosumab (2015-2021年).
- 根据剂量计划 (最多8周的延迟) 将其分为坚持和不坚持的组.
- 两组之间的新脆弱性骨折率的比较.
主要成果:
- 59.05%的患者坚持使用德诺苏马布,而40.95%的患者不坚持.
- 发生了32个新的脆弱性骨折,17个在坚持的群体中,15个在不坚持的群体中.
- 在坚持和不坚持的组之间没有观察到骨折风险或骨折类型的显著差异.
结论:
- 停止使用登苏马布后的骨折可能反映了骨质疏松症的进展,而不是反弹效应.
- 应避免计划外停止治疗以优化患者的治疗结果.
- 需要进一步研究停药后长期骨折风险.
相关概念视频
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Bone Remodeling
40.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.2K
Drug Dosing: Geriatric Patients
215
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
215
Osteoclasts in Bone Remodeling
3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K


